Figure 1From: Metabolic response by FDG-PET to imatinib correlates with exon 11 KIT mutation and predicts outcome in patients with mucosal melanomaWaterfall plots of metabolic response by lesion (a) and patient (b). Three subjects were classified as PMD based on the presence of new lesions rather than % change SUVmax & have not been included in the waterfall plot above.Back to article page